Jailendra Singh
Stock Analyst at Truist Securities
(0.93)
# 3,975
Out of 5,113 analysts
184
Total ratings
28.43%
Success rate
-23.78%
Average return
Main Sectors:
Stocks Rated by Jailendra Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDLN Medline | Initiates: Buy | $52 | $46.00 | +13.04% | 1 | Jan 12, 2026 | |
| IQV IQVIA Holdings | Maintains: Buy | $265 → $290 | $235.31 | +23.24% | 18 | Jan 8, 2026 | |
| ICLR ICON Public Limited Company | Downgrades: Hold | $231 → $222 | $186.87 | +18.80% | 11 | Jan 8, 2026 | |
| FTRE Fortrea Holdings | Upgrades: Buy | $12 → $22 | $16.83 | +30.72% | 1 | Jan 8, 2026 | |
| PRVA Privia Health Group | Reiterates: Buy | $30 → $31 | $23.94 | +29.49% | 8 | Nov 10, 2025 | |
| EVH Evolent Health | Maintains: Buy | $16 → $10 | $3.94 | +153.81% | 8 | Nov 10, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $436 → $555 | $588.05 | -5.62% | 6 | Oct 27, 2025 | |
| PHR Phreesia | Maintains: Buy | $35 → $36 | $15.84 | +127.27% | 7 | Sep 8, 2025 | |
| HIMS Hims & Hers Health | Maintains: Hold | $48 → $37 | $29.62 | +24.92% | 11 | Aug 18, 2025 | |
| WAY Waystar Holding | Maintains: Buy | $50 → $51 | $29.98 | +70.11% | 3 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $24 → $27 | $25.22 | +7.06% | 10 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $52 → $61 | $40.63 | +50.14% | 9 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $48 | $42.56 | +12.78% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $10 → $9 | $6.33 | +42.18% | 16 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.5 → $5.5 | $2.56 | +114.84% | 12 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $12 → $7.5 | $4.87 | +54.00% | 7 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $46 | $27.16 | +69.37% | 5 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $261 → $210 | $222.00 | -5.41% | 7 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $14 | $10.88 | +28.68% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.4 → $6.5 | $0.99 | +555.90% | 8 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $13 | $3.47 | +274.64% | 11 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $30 → $24 | $2.43 | +887.65% | 2 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 → $4 | $1.64 | +143.90% | 4 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $58 | $208.33 | -72.16% | 2 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $90 → $45 | $2.38 | +1,790.76% | 7 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $230 → $333 | $820.23 | -59.40% | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $9 | $2.59 | +247.49% | 2 | May 19, 2021 |
Medline
Jan 12, 2026
Initiates: Buy
Price Target: $52
Current: $46.00
Upside: +13.04%
IQVIA Holdings
Jan 8, 2026
Maintains: Buy
Price Target: $265 → $290
Current: $235.31
Upside: +23.24%
ICON Public Limited Company
Jan 8, 2026
Downgrades: Hold
Price Target: $231 → $222
Current: $186.87
Upside: +18.80%
Fortrea Holdings
Jan 8, 2026
Upgrades: Buy
Price Target: $12 → $22
Current: $16.83
Upside: +30.72%
Privia Health Group
Nov 10, 2025
Reiterates: Buy
Price Target: $30 → $31
Current: $23.94
Upside: +29.49%
Evolent Health
Nov 10, 2025
Maintains: Buy
Price Target: $16 → $10
Current: $3.94
Upside: +153.81%
Medpace Holdings
Oct 27, 2025
Maintains: Hold
Price Target: $436 → $555
Current: $588.05
Upside: -5.62%
Phreesia
Sep 8, 2025
Maintains: Buy
Price Target: $35 → $36
Current: $15.84
Upside: +127.27%
Hims & Hers Health
Aug 18, 2025
Maintains: Hold
Price Target: $48 → $37
Current: $29.62
Upside: +24.92%
Waystar Holding
Jul 17, 2025
Maintains: Buy
Price Target: $50 → $51
Current: $29.98
Upside: +70.11%
Jul 17, 2025
Maintains: Hold
Price Target: $24 → $27
Current: $25.22
Upside: +7.06%
Jul 17, 2025
Maintains: Hold
Price Target: $52 → $61
Current: $40.63
Upside: +50.14%
Jun 16, 2025
Initiates: Buy
Price Target: $48
Current: $42.56
Upside: +12.78%
May 27, 2025
Maintains: Hold
Price Target: $10 → $9
Current: $6.33
Upside: +42.18%
Apr 10, 2025
Maintains: Hold
Price Target: $6.5 → $5.5
Current: $2.56
Upside: +114.84%
Apr 10, 2025
Maintains: Hold
Price Target: $12 → $7.5
Current: $4.87
Upside: +54.00%
Mar 18, 2025
Maintains: Buy
Price Target: $50 → $46
Current: $27.16
Upside: +69.37%
Jan 13, 2025
Maintains: Hold
Price Target: $261 → $210
Current: $222.00
Upside: -5.41%
Jul 2, 2024
Maintains: Buy
Price Target: $17 → $14
Current: $10.88
Upside: +28.68%
May 24, 2024
Maintains: Hold
Price Target: $6.4 → $6.5
Current: $0.99
Upside: +555.90%
May 4, 2022
Maintains: Neutral
Price Target: $16 → $13
Current: $3.47
Upside: +274.64%
Feb 24, 2022
Maintains: Neutral
Price Target: $30 → $24
Current: $2.43
Upside: +887.65%
Feb 8, 2022
Downgrades: Neutral
Price Target: $14 → $4
Current: $1.64
Upside: +143.90%
Feb 4, 2022
Maintains: Neutral
Price Target: $60 → $58
Current: $208.33
Upside: -72.16%
Jan 7, 2022
Downgrades: Underperform
Price Target: $90 → $45
Current: $2.38
Upside: +1,790.76%
Jan 7, 2022
Upgrades: Outperform
Price Target: $230 → $333
Current: $820.23
Upside: -59.40%
May 19, 2021
Maintains: Neutral
Price Target: $10 → $9
Current: $2.59
Upside: +247.49%